A growing focus on long-term respiratory wellness has elevated the role of pulmonary rehabilitation and preventive care in managing chronic lung diseases. Combining structured exercise, patient education, and behavioral intervention, pulmonary rehabilitation significantly improves functional status, quality of life, and hospital readmission rates in individuals with COPD, interstitial lung disease, and post-COVID fibrosis. Preventive care strategies now emphasize early spirometry, vaccination adherence, and exposure reduction in at-risk populations. Pulmonary Rehabilitation and Preventive Care is also benefiting from community-based delivery models and home-rehab technologies, ensuring access for underserved and mobility-limited patients. Integrating nutritional support, psychological counseling, and smoking cessation programs creates a comprehensive approach that addresses both physiologic and social determinants of respiratory health. Preventive care is no longer peripheral—it's foundational to resilient pulmonary systems and sustainable health outcomes.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation